精神医学
RECOVER trial suggests vagus nerve stimulation benefits some patients with severe treatment-resistant depression for at least two years
AIによるレポート AIによって生成された画像 事実確認済み
An implanted device that stimulates the vagus nerve was associated with sustained improvements in symptoms, functioning and quality of life among adults with long-standing, treatment-resistant major depression, according to researchers reporting two-year follow-up data from the ongoing RECOVER study led by Washington University School of Medicine in St. Louis.
Carmen Prada, head of mental health at Córdoba's Hospital Reina Sofía, testified Thursday in court that her patient Francisco Miguel León Benítez had no suicidal intentions when he died in 2020. Prosecutors seek four years in prison, while the private accusation demands eight for two involuntary homicides, including that of a man the patient killed in 2015. The family accuses the doctor of failing to order involuntary commitment despite repeated requests since 2010.
AIによるレポート
Uppsala county's psychiatric ambulance, operating only eight hours a day, misses 60 to 80 percent of mental health alarms due to resource shortages. Hospital board chair Neil Ormerod (V) wants to extend operating hours but lacks funding. Police report a clear difference when the service is active.
A new psychiatric diagnosis aims to identify a forgotten patient group fearing they disgust others with their smell. This results in unnecessary washing of clean clothes. The condition, known as ORD, stems from a constant pursuit of freshness.
AIによるレポート
スウェーデン、デンマーク、ドイツの科学者らが、多遺伝子リスクスコアを使用した遺伝子検査を作成し、個々の人に最適な抗うつ薬や抗不安薬を予測するのを助ける。このアプローチは研究データベースでテストされ、うつ病や不安障害の患者のほぼ半数に影響を与える試行錯誤のプロセスを減らす可能性がある。主任研究者のフレドリック・アース教授は、数百万人の救済を加速させる安価で効果的な検査の未来を思い描いている。